Case | Age (year) | sex | Indication for OLT | HIV CDC classification Pre-OLT | CD4 cell count (cells/ul) Pre-OLT | HIV-RNA (copies/ml) Pre-OLT | HBV-DNA (copies/ml) Pre-OLT | MELD score | HAART Pre-OLT | Latest CD4 cell count (cells/ul) | Latest HIV-RNA (copies/ml) | Latest HBV-DNA (copies/ml) | HAART after OLT | Hospital stays (d) | Complications | Follow-up (mo) | Outcome |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 61 | Male | HBV-ACLF | A3 | 42 | ND | 4.23E + 06 | 40 | DTG + 3TC + TAF | 209 | ND | < 20 | DTG + 3TC + TAF | 37 | Acute rejection | 43 | Alive |
2 | 52 | Male | HBV-DLC | C3 | 140 | < 500 | 6.71E + 02 | 10 | FTC + TAF + RAL | 317 | ND | < 20 | FTC + TAF + RAL | 18 | No | 39 | Alive |
3 | 47 | Male | HBV-ACLF | A3 | 181 | < 500 | 4.51E + 04 | 35 | TAF + FTC + DTG | 478 | < 250 | < 20 | TAF + FTC + DTG | 39 | No | 37 | Alive |
4 | 46 | Male | HBV-ACLF | A3 | 121 | < 500 | < 200 | 40 | DTG + ABT | 476 | ND | < 20 | DTG + ABT + TAF | 64 | No | 36 | Alive |
5 | 34 | Male | HBV-ACLF | A3 | 113 | < 500 | < 200 | 31 | 3TC + DTG | 244 | < 250 | < 20 | B/F/TAF | 31 | No | 15 | Alive |
6 | 65 | Male | HBV-ACLF | A3 | 165 | < 500 | 2.53E + 04 | 34 | TDF + FTC + RAL | 231 | < 250 | < 100 | TDF + FTC + RAL | 31 | No | 12 | Alive |
7 | 58 | Male | HBV-ACLF | A3 | 38 | < 500 | < 100 | 31 | 3TC + DTG | 3 | < 500 | < 100 | DTG + ABT + TAF | 66 | Pulmonary infections, acute renal failure | 2 | Dead |